Back to Search
MICHAEL PRESTA, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1427345610Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
63121
Research & Publications (20)
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
PMID 19627396·J Cell Mol Med·2010
7-preclinical
Determination of Flavonoids and Resveratrol in Wine by Turbulent-Flow Chromatography-LC-MS.
PMID 19554204·Chromatographia·2009
8-other
Fibroblast growth factor 2-induced angiogenesis in zebrafish: the zebrafish yolk membrane (ZFYM) angiogenesis assay.
PMID 18657228·J Cell Mol Med·2009
7-preclinical
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.
PMID 19625102·Immunobiology·2009
6-review
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.
PMID 19541589·Eur Cytokine Netw·2009
6-review
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells.
PMID 19549074·J Cell Mol Med·2009
7-preclinical
HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium.
PMID 19661268·Blood·2009
7-preclinical
A pro-inflammatory signature mediates FGF2-induced angiogenesis.
PMID 18624773·J Cell Mol Med·2009
7-preclinical
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers.
PMID 19074851·Mol Cancer Ther·2008
7-preclinical
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish.
PMID 18326814·Blood·2008
7-preclinical
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.
PMID 17996481·Int J Biochem Cell Biol·2008
8-other
Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm.
PMID 18505784·Blood·2008
7-preclinical
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.
PMID 18922791·J Biol Chem·2008
7-preclinical
Dendritic cell-endothelial cell cross-talk in angiogenesis.
PMID 17692569·Trends Immunol·2007
6-review
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation.
PMID 17310502·J Pathol·2007
8-other
Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
PMID 17409396·Cancer Res·2007
7-preclinical
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement.
PMID 17456474·J Biol Chem·2007
4-observational
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.
PMID 17627537·Curr Pharm Des·2007
6-review
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
PMID 17077323·Blood·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 47 NEW SCOTLAND AVE, DEPARTMENT OF EMERGENCY MEDICINE
ALBANY, NY 12208 - Phone
- (518) 262-3095
Quick Facts
- NPI
- 1427345610
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile